Latest News
Feature
ONC aims to help docs, patients with information sharing in proposed rule
The HHS wants to help health professionals and patients securely and easily access electronic health information using smartphones and mobile...
Conference Coverage
Fund projects, not people to address gender bias in research funding
LONDON – Female investigators are less likely to secure research funding than men simply because they are women, according to research published...
Feature
Survey: Health care costs, access unlikely to improve in 2019
Most physicians expect the federal government to continue efforts to defund the ACA.
Conference Coverage
Vaccination and antiviral treatment do not affect stroke risk following shingles
HONOLULU – Preventing shingles through vaccination might be the best method for preventing shingles-associated acute...
Literature Review
International survey probes oxygen’s efficacy for cluster headache
Oxygen is a highly effective therapy with few complications, according to a survey of patients with cluster headache.
From the Journals
In California, opioids most often prescribed in low-income, mostly white areas
Opioid-related overdose deaths are highest in low-income white areas.
News from the FDA/CDC
FDA issues warnings to companies selling illegal Alzheimer’s treatments
The FDA targeted more than 58 products.
From the Journals
High prevalence of sleep problems in children with autism spectrum disorder
Children with ASD are more likely to have anxiety, which may predispose them to sleep problems.
Conference Coverage
Most U.S. tPA-eligible stroke patients now get treated within an hour
The most recent phase of the Target: Stroke program met its tPA delivery-time target in September 2018.
Conference Coverage
Socioeconomic status, race found to impact CPAP compliance
SAN DIEGO – Identifying patients at risk for noncompliance and treating comorbid symptoms could improve compliance to CPAP therapy.
Feature
Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale
More than 700 generics, or about 43%, still weren’t on the market as of early January, a KHN data analysis of FDA and drug list price records...